Analyzing health data enables researchers to improve treatments, optimize clinical care, and determine efficacy in the real world, post-clinical trials and approval. However, sources and databases currently in use are time and cost intensive to collect, curate, integrate, and deploy.
Robert Currie offers an overview of the Cancer Genome Trust, which was developed to enable providers to openly share consented patients’ deidentified health data using Ethereum and IPFS at a clinical-relevant time scale. Robert also discusses a pilot at UCSF that includes genetic, clinical, and imaging patient data.
Rob Currie is CTO at the UCSC Genomics Institute. Rob has over 25 years of experience as a senior executive at Silicon Valley early-stage technology companies, including Universal Audio, Dash Navigation/Blackberry, Strangeberry/TiVo, Marimba/BMC, and Digidesign/Avid in fields including distributed systems management, signal processing, and geospatial navigation. Rob holds a BS in EECS from UC Berkeley and an MBA from the University of Chicago Booth School of Business.
©2018, O'Reilly Media, Inc. • (800) 889-8969 or (707) 827-7019 • Monday-Friday 7:30am-5pm PT • All trademarks and registered trademarks appearing on oreilly.com are the property of their respective owners. • firstname.lastname@example.org